[1] |
Shi D, Li X, Chen H, et al. High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F⁃actin cytoskeleton in systemic lupus erythematosus[J]. Pathol Biol (Paris), 2014, 62(6): 382⁃390. DOI: 10.1016/j.patbio.2014. 07.009.
|
[2] |
Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells[J]. Blood, 2007, 110(10): 3499⁃3506. DOI: 10.1182/ blood⁃2007⁃02⁃069716.
|
[3] |
Sun LY, Zhang HY, Feng XB, et al. Abnormality of bone marrow⁃derived mesenchymal stem cells in patients with systemic lupus erythematosus[J]. Lupus, 2007, 16(2): 121⁃128. DOI: 10.1177/0961203306075793.
|
[4] |
Nie Y, Lau C, Lie A, et al. Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus[J]. Lupus, 2010, 19(7): 850⁃859. DOI: 10.1177/0961203309361482.
|
[5] |
Li X, Liu L, Meng D, et al. Enhanced apoptosis and senescence of bone⁃marrow⁃derived mesenchymal stem cells in patients with systemic lupus erythematosus[J]. Stem Cells Dev, 2012, 21(13): 2387⁃2394. DOI: 10.1089/scd.2011.0447.
|
[6] |
Tang XL, Griffith JF, Qin L, et al. SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength[J]. Lupus, 2013, 22(11): 1162⁃1168. DOI: 10.1177/0961203313498802.
|
[7] |
孟德芳, 刘蕾, 汤郁, 等. 系统性红斑狼疮女性患者骨髓间充质干细胞衰老与细胞内活性氧的相关性研究[J]. 中华风湿病学杂志, 2011, 15(4): 229⁃233. DOI: 10.3760/cma.j.issn.1007⁃7480. 2011.04.004.
|
|
Meng DF, Liu L, Tang Y, et al. Association of bone marrow mesenchymal stem cells and intracellular reactive oxygen species levels in patients with systemic lupus erythematosus[J]. Chin J Rheumatol, 2011,15(4): 229⁃233. DOI: 10.3760/cma.j.issn.1007⁃7480.2011.04.004.
|
[8] |
Buseman CM, Wright WE, Shay JW. Is telomerase a viable target in cancer?[J]. Mutat Res, 2012, 730(1⁃2): 90⁃97. DOI: 10.1016/j.mrfmmm.2011.07.006.
|
[9] |
Armstrong L, Lako M, Lincoln J, et al. mTert correlates with telomerase activity during the differentiation of murine embryonic stem cells[J]. Mech Dev, 2000, 97(1⁃2): 109⁃116. DOI: 10.1016/S0925⁃4773(00)00423⁃8.
|
[10] |
Madonna R, Taylor DA, Geng YJ, et al. Transplantation of mesen⁃chymal cells rejuvenated by the over of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia[J]. Circ Res, 2013, 113(7): 902⁃914. DOI: 10.1161/CIRCRESAHA.113.301690.
|
[11] |
Kurosaka D, Yasuda J, Yoshida K, et al. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus[J]. J Rheumatol, 2006, 33(6): 1102⁃ 1107.
|
[12] |
Tang Y, Xie H, Chen J, et al. Activated NF⁃kappaB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling[J]. Stem Cells Dev, 2013, 22(4): 668⁃678. DOI: 10.1089/scd.2012.0226.
|
[13] |
Ross SE, Hemati N, Longo KA, et al. Inhibition of adipogenesis by Wnt signaling[J]. Science, 2000, 289(5481): 950⁃953. DOI: 10.1126/science.289.5481.950.
|
[14] |
Bocelli⁃Tyndall C, Bracci L, Spagnoli G, et al. Bone marrow mesenchymal stromal cells (BM⁃MSCs) from healthy donors and auto⁃immune disease patients reduce the proliferation of autologous⁃ and allogeneic⁃stimulated lymphocytes in vitro[J]. Rheumatology (Oxford), 2007, 46(3): 403⁃408. DOI: 10.1093/rheumatology/kel267.
|
[15] |
Gu Z, Cao X, Jiang J, et al. Upregulation of p16INK4A promotes cellular senescence of bone marrow⁃derived mesenchymal stem cells from systemic lupus erythematosus patients[J]. Cell Signal, 2012, 24(12): 2307⁃2314. DOI: 10.1016/j.cellsig.2012.07.012.
|
[16] |
Gu Z, Jiang J, Tan W, et al. p53/p21 Pathway involved in mediating cellular senescence of bone marrow⁃derived mesenchymal stem cells from systemic lupus erythematosus patients[J]. Clin Dev Immunol, 2013, 2013: 13443. DOI: 10.1155/2013/134243.
|
[17] |
Tan W, Gu Z, Shen B, et al. PTEN/Akt⁃p27 signaling promote the BM⁃MSCs senescence and apoptosis in SLE patients[J]. J Cell Biochem, 2015, 116(8):1583⁃1594. DOI: 10.1002/jcb.25112.
|
[18] |
Shibata KR, Aoyama T, Shima Y, et al. Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion[J]. Stem Cells, 2007, 25(9): 2371⁃2382. DOI: 10.1634/stemcells.2007⁃0225.
|
[19] |
Gu Z, Tan W, Feng G, et al. Wnt/beta⁃catenin signaling mediates the senescence of bone marrow⁃mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway[J]. Mol Cell Biochem, 2014, 387(1⁃2): 27⁃37. DOI: 10.1007/s11010⁃013⁃1866⁃5.
|
[20] |
Gu Z, Meng Y, Tao T, et al. Endoplasmic reticulum stress participates in the progress of senescence of bone marrow⁃derived mesenchymal stem cells in patients with systemic lupus erythematosus[J]. Cell Tissue Res, 2015, 361(2):497⁃508. DOI: 10.1007/s00441⁃015⁃2131⁃x.
|
[21] |
Strickland FM, Richardson BC. Epigenetics in human auto⁃immunity. Epigenetics in autoimmunity ⁃ DNA methylation in systemic lupus erythematosus and beyond[J]. Autoimmunity, 2008, 41(4): 278⁃286. DOI: 10.1080/08916930802024616.
|
[22] |
Ikehara S. new strategies for allogeneic BMT[Z]. 2003: 32, s73⁃s75. DOI: 10.1038/sj.bmt.1703948.
|
[23] |
Sun L, Akiyama K, Zhang H, et al. Mesenchymal stem cell trans⁃plantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans[J]. Stem Cells, 2009, 27(6): 1421⁃1432. DOI: 10.1002/stem.68.
|
[24] |
Carrion F, Nova E, Ruiz C, et al. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients[J]. Lupus, 2010, 19(3): 317⁃322. DOI: 10.1177/0961203309348983.
|
[25] |
Baxter MA, Wynn RF, Jowitt SN, et al. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion[J]. Stem Cells, 2004, 22(5): 675⁃682. DOI: 10.1634/stemcells.22⁃5⁃675.
|